Dipeptidyl peptidase 4 (DPP-4) inhibitors and cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM): a systematic review and meta-analysis

Overview of attention for article published in BMC Pharmacology and Toxicology, March 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)

Mentioned by

policy: 1 policy source
twitter: 2 X users

patent: 1 patent

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 71 Mendeley

Summary Policy documents X Patents Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,034 followers.

RT @SOCIEMUCV: Para leer sobre inhibidores de la DPP-4 y riesgo cardiovascular en pacientes con diabetes mellitus tipo 2, puede acceder al…

17 May 2019

Reply Repost Favourite

Para leer sobre inhibidores de la DPP-4 y riesgo cardiovascular en pacientes con diabetes mellitus tipo 2, puede acceder al siguiente enlace: https://t.co/8pfZwkMnpI

17 May 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.